Giovanni Grignani (G Grignani)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 30

Top Venues

Future oncology (London, England)

Cancer

Cancers

Cancer medicine

Candiolo Cancer Institute - FPO IRCCS

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Candiolo Cancer Institute - FPO IRCCS Jun 1o 1999

Italy

Director Sarcoma Unit :: Medical Oncology

Publications

Paola Zagami, Alessandro Comandone, Marco Fiore, Giacomo Giulio Baldi, Giovanni Grignani, Bruno Vincenzi, Alessandro Gronchi, Gabriele Antonarelli, Antonella Boglione, Elisabetta Pennacchioli, Giuseppe Curigliano, Fabio Conforti, Tommaso Martino De Pas
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centers. Cancer medicine (2023)
Giovanni Grignani, Axel Le Cesne, Javier Martín-Broto
Trabectedin as second-line treatment in advanced soft tissue sarcoma: quality of life and safety outcomes. Future oncology (London, England) 18 (30s) (2022)
Giovanni Grignani, Alessandra Merlini, Sandra Aliberti
Being the ultimate travel companion of a patient with uterine leiomyosarcoma. Future oncology (London, England) 18 (29s) (2022)
Axel Le Cesne, Javier Martín-Broto, Giovanni Grignani
A review of the efficacy of trabectedin as second-line treatment of advanced soft tissue sarcoma. Future oncology (London, England) 18 (30s) (2022)
Erika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, Ilaria Cerviere, Enrico Berrino, Caterina Marchio, Lidia Giraudo, Marco Basiricò, Annamaria Massa, Chiara Donini, Valeria Leuci, Ramona Rotolo, Federica Galvagno, Letizia Vitali, Alessia Proment, Soldano Ferrone, Alberto Pisacane, Ymera Pignochino, Massimo Aglietta, Giovanni Grignani, Giulia Mesiano, Dario Sangiolo
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST. International journal of molecular sciences 23 (18) (2022)
Anna Maria Frezza, Silvia Stacchiotti, Frederic Chibon, Jean-Michelle Coindre, Antoine Italiano, Cleofe Romagnosa, Silvia Bagué, Angelo Paolo Dei Tos, Luca Braglia, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martin Broto, Antonio Lopez Pousa, Giovanni Grignani, Antonella Brunello, Jean-Yves Blay, Robert Diaz Beveridge, Iwona Lugowska, Tom Lesluyes, Roberta Maestro, Franco Domenico Merlo, Paolo Giovanni Casali, Alessandro Gronchi
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study. Cancer medicine (2022)
Samuel Hidalgo-Ríos, Jaime Carrillo-García, David S Moura, Silvia Stacchiotti, Antonio López-Pousa, Andrés Redondo, Antoine Italiano, Antonio Gutierrez, Giovanni Grignani, Nadia Hindi, Jose Antonio Lopez-Guerrero, Xavier García Del Muro, Javier Martínez Trufero, Emanuela Palmerini, Ana Sebio García, Daniel Bernabeu, Axel Le Cesne, Paolo Giovanni Casali, Jean Yves Blay, Josefina Cruz Jurado, Javier Martín-Broto
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib. Cancers 14 (17) (2022)
Ramona Rotolo, Valeria Leuci, Chiara Donini, Federica Galvagno, Annamaria Massa, Maria Chiara De Santis, Serena Peirone, Giovanni Medico, Martina Sanlorenzo, Igor Vujic, Loretta Gammaitoni, Marco Basiricò, Luisella Righi, Chiara Riganti, Iris Chiara Salaroglio, Francesca Napoli, Fabrizio Tabbò, Annapaola Mariniello, Elisa Vigna, Chiara Modica, Lorenzo D'Ambrosio, Giovanni Grignani, Riccardo Taulli, Emilio Hirsch, Matteo Cereda, Massimo Aglietta, Giorgio Vittorio Scagliotti, Silvia Novello, Paolo Bironzo, Dario Sangiolo
Novel lymphocyte-independent antitumor activity by PD-1 blocking antibody against PD-1+ chemoresistant lung cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Francesca Spada, Paolo Bossi, Corrado Caracò, Vanna Chiarion Sileni, Angelo Paolo Dei Tos, Nicola Fazio, Giovanni Grignani, Michele Maio, Pietro Quaglino, Paola Queirolo, Paolo Antonio Ascierto, null null
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel. Journal for immunotherapy of cancer 10 (6) (2022)
Nizar M Tannir, Daniel C Cho, Adi Diab, Mario Sznol, Mehmet Asim Bilen, Arjun V Balar, Giovanni Grignani, Erika Puente, Lily Tang, David Chien, Ute Hoch, Arkopal Choudhury, Danni Yu, Sue L Currie, Mary A Tagliaferri, Jonathan Zalevsky, Arlene O Siefker-Radtke, Michael E Hurwitz
Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study. Journal for immunotherapy of cancer 10 (4) (2022)
Giacomo Giulio Baldi, Salvatore Lo Vullo, Giovanni Grignani, Bruno Vincenzi, Giuseppe Badalamenti, Marinella Mastore, Ciriaco Buonomenna, Carlo Morosi, Marta Barisella, Anna Maria Frezza, Salvatore Provenzano, Noemi Simeone, Fernanda Picozzi, Luigi Mariani, Paolo G Casali, Silvia Stacchiotti
Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case-series analysis from the Italian Rare Cancers Network. Cancer 128 (7) (2022)
Javier Martín-Broto, Nadia Hindi, Giovanni Grignani, Alessandra Merlini, Tony Ibrahim, Axel Le Cesne
Experience with second-line trabectedin in daily clinical practice: case studies. Future oncology (London, England) 18 (30s) (2022)
Fabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo, Paolo Becco, Luca Paruzzo, Stefano Poletto, Alessandra Polo, Monica Mangioni, Milena Salierno, Massimo Berger, Rosanna Pessolano, Francesco Saglio, Daniela Gottardi, Delia Rota-Scalabrini, Giovanni Grignani, Marco Fizzotti, Ivana Ferrero, Pio Manlio Mirko Frascione, Lorenzo D'Ambrosio, Valentina Gaidano, Loretta Gammaitoni, Dario Sangiolo, Andrea Saglietto, Elena Vassallo, Alessandro Cignetti, Massimo Aglietta, Franca Fagioli
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors. Journal of clinical medicine 10 (6) (2021)
Ymera Pignochino, Giovanni Crisafulli, Giorgia Giordano, Alessandra Merlini, Enrico Berrino, Maria Laura Centomo, Giulia Chiabotto, Silvia Brusco, Marco Basiricò, Elena Maldi, Alberto Pisacane, Valeria Leuci, Dario Sangiolo, Lorenzo D'Ambrosio, Massimo Aglietta, Bernd Kasper, Alberto Bardelli, Giovanni Grignani
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study. Cancers 13 (24) (2021)
Sebastian Dorin Asaftei, Nadia Puma, Anna Paioli, Marco Petraz, Carlo Morosi, Marta Giorgia Podda, Angela Tamburini, Emanuela Palmerini, Luca Coccoli, Giovanni Grignani, Carla Manzitti, Rossella Bertulli, Francesco De Leonardis, Marco Rabusin, Anna Campello, Elisa Tirtei, Piero Picci, Arcangelo Prete, Alessandra Longhi, Franca Fagioli, Roberto Luksch
Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study. Cancers 13 (12) (2021)
Anna Maria Frezza, Vinod Ravi, Salvatore Lo Vullo, Bruno Vincenzi, Francesco Tolomeo, Tom Wei-Wu Chen, Pawel P Teterycz, Giacomo G Baldi, Antoine Italiano, Nicolas Penel, Antonella Brunello, Florance Duffaud, Nadia Hindi, Shintaro Iwata, Alannah Smrke, Alexander Fedenko, Hans Gelderblom, Winette Van Der Graaf, Aurore Vozy, Elizabeth Connolly, Massimiliano Grassi, Robert S Benjamin, Javier-Martin Broto, Giovanni Grignani, Robin L Jones, Akira Kawai, Andrzej Tysarowski, Luigi Mariani, Paolo G Casali, Silvia Stacchiotti
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature. Cancer medicine 10 (8) (2021)
Mrinal Gounder, Albiruni R Abdul Razak, Adrienne M Gilligan, Hoyee Leong, Xiwen Ma, Neeta Somaiah, Sant P Chawla, Javier Martin-Broto, Giovanni Grignani, Scott M Schuetze, Bruno Vincenzi, Andrew J Wagner, Bartosz Chmielowski, Robin L Jones, Jatin Shah, Sharon Shacham, Michael Kauffman, Richard F Riedel, Steven Attia
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma. Future oncology (London, England) 17 (22) (2021)
Javier Martín-Broto, Nadia Hindi, Giovanni Grignani, Javier Martinez-Trufero, Andres Redondo, Claudia Valverde, Silvia Stacchiotti, Antonio Lopez-Pousa, Lorenzo D'Ambrosio, Antonio Gutierrez, Herminia Perez-Vega, Victor Encinas-Tobajas, Enrique de Alava, Paola Collini, Maria Peña-Chilet, Joaquin Dopazo, Irene Carrasco-Garcia, Maria Lopez-Alvarez, David S Moura, Jose A Lopez-Martin
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial. Journal for immunotherapy of cancer 8 (2) (2021)
Giorgia Giordano, Alessandra Merlini, Giulio Ferrero, Giulia Mesiano, Erika Fiorino, Silvia Brusco, Maria Laura Centomo, Valeria Leuci, Lorenzo D'Ambrosio, Massimo Aglietta, Dario Sangiolo, Giovanni Grignani, Ymera Pignochino
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma. Cells 10 (11) (2021)
Massimo Eraldo Abate, Silvia Cammelli, Letizia Ronchi, Barbara Diletto, Lorenza Gandola, Anna Paioli, Alessandra Longhi, Emanuela Palmerini, Nadia Puma, Angela Tamburini, Maurizio Mascarin, Elisa Coassin, Arcangelo Prete, Sebastian Dorin Asaftei, Carla Manzitti, Gianni Bisogno, Marta Pierobon, Luca Coccoli, Mariella Capasso, Giovanni Grignani, Giuseppe Maria Milano, Valentina Kiren, Franca Fagioli, Stefano Ferrari, Piero Picci, Elisa Carretta, Roberto Luksch
Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study. Cancers 13 (11) (2021)
Sandro Pasquali, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martin-Broto, Antonio Lopez-Pousa, Giovanni Grignani, Antonella Brunello, Jean Yves Blay, Oscar Tendero, Robert Diaz-Beveridge, Virginia Ferraresi, Iwona Lugowska, Gabriele Infante, Luca Braglia, Domenico Franco Merlo, Valeria Fontana, Emanuela Marchesi, Davide Maria Donati, Elena Palassini, Giuseppe Bianchi, Andrea Marrari, Carlo Morosi, Silvia Stacchiotti, Silvia Bagué, Jean Michel Coindre, Angelo Paolo Dei Tos, Piero Picci, Paolo Bruzzi, Rosalba Miceli, Paolo Giovanni Casali, Alessandro Gronchi
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer (2021)
Emanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, Angela Buonadonna, Antonella Romanini, Giuseppe Badalamenti, Virginia Ferraresi, Bruno Vincenzi, Alessandro Comandone, Antonio Pizzolorusso, Antonella Brunello, Fabio Gelsomino, Tommaso Martino De Pas, Toni Ibrahim, Federica Grosso, Francesca Zanelli, Maria Abbondanza Pantaleo, Laura Milesi, Libero Ciuffreda, Vittorio Ferrari, Emanuela Marchesi, Irene Quattrini, Alberto Righi, Elisabetta Setola, Elisa Carretta, Piero Picci, Stefano Ferrari
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group. Cancers 13 (5) (2021)
Winan J van Houdt, Marco Fiore, Francesco Barretta, Piotr Rutkowski, Jean Yves Blay, Guy Lahat, Dirk Strauss, Ricardo J Gonzalez, Nita Ahuja, Giovanni Grignani, Vittorio Quagliuolo, Eberhard Stoeckle, Antonino De Paoli, Yvonne Schrage, Kenneth Cardona, Elisabetta Pennacchioli, Venu G Pillarisetty, Carolyn Nessim, Carol J Swallow, Sanjay P Bagaria, Robert Canter, John T Mullen, Dario Callegaro, Mark Fairweather, Rosalba Miceli, Chandrajit P Raut, Alessandro Gronchi, Rebecca A Gladdy
Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG. Cancer 126 (22) (2020)
Lorenzo D'Ambrosio, Nathan Touati, Jean Yves Blay, Giovanni Grignani, Ronan Flippot, Anna M Czarnecka, Sophie Piperno-Neumann, Javier Martin-Broto, Roberta Sanfilippo, Daniela Katz, Florence Duffaud, Bruno Vincenzi, Daniel P Stark, Filomena Mazzeo, Armin Tuchscherer, Christine Chevreau, Jenny Sherriff, Anna Estival, Saskia Litière, Ward Sents, Isabelle Ray-Coquard, Francesco Tolomeo, Axel Le Cesne, Piotr Rutkowski, Silvia Stacchiotti, Bernd Kasper, Hans Gelderblom, Alessandro Gronchi, null null
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Cancer 126 (11) (2020)
Emanuela Palmerini, Elisabetta Setola, Giovanni Grignani, Lorenzo D'Ambrosio, Alessandro Comandone, Alberto Righi, Alessandra Longhi, Marilena Cesari, Anna Paioli, Rossella Hakim, Michela Pierini, Emanuela Marchesi, Daniel Vanel, Ymera Pignochino, Davide Maria Donati, Piero Picci, Stefano Ferrari
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series. Cells 9 (11) (2020)
Sandra Aliberti, Sara Miano, Francesco Tolomeo, Alessandra Merlini, Massimo Aglietta, Giovanni Grignani
Response to eribulin in a patient with metastatic uterine leiomyosarcoma: a case report. Future oncology (London, England) 16 (1s) (2020)
Federica Grosso, Lorenzo D'Ambrosio, Massimo Zucchetti, Toni Ibrahim, Stefano Tamberi, Cristina Matteo, Eliana Rulli, Danila Comandini, Emanuela Palmerini, Giacomo Giulio Baldi, Andrea DeCensi, Marina Bergaglio, Domenico Marra, Emanuela Marchesi, Giacomo Siri, Maurizio D'Incalci, Giovanni Grignani
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group. Cancer 126 (21) (2020)
William W Tseng, Francesco Barretta, Lorenzo Conti, Giovanni Grignani, Francesco Tolomeo, Markus Albertsmeier, Martin K Angele, Piotr Rutkowski, Jacek Skoczylas, Antonino De Paoli, Federico Navarria, Chandrajit P Raut, Mark Fairweather, Jeffrey M Farma, Carolyn Nessim, Neha Goel, Valerie P Grignol, Samuel J Ford, Kenneth Cardona, Ty Subhawong, Hannah L Tattersall, Rachel M Lee, James S Hu, Margaret von Mehren, Roberta Sanfilippo, Alessandro Gronchi
Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Cancer 127 (5) (2020)
M Fioramonti, V Fausti, F Pantano, M Iuliani, G Ribelli, F Lotti, Y Pignochino, Giovanni Grignani, D Santini, G Tonini, B Vincenzi
Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment. Scientific reports 8 (1) (2018)
Lorenzo D'Ambrosio, Erica Palesandro, Marina Moretti, Giuseppe Pelosi, Alessandra Fabbri, Fabrizio Carnevale Schianca, Massimo Aglietta, Giovanni Grignani
Alpha-fetoprotein elevation in NUT midline carcinoma: a case report. BMC cancer 17 (1) (2017)

Giovanni Grignani.css-eqlu8i{font-size:small;padding-left:4px;} (G Grignani)

Publication Activity (10 Years)

Top Topics

Top Venues

Giovanni Grignani (G Grignani)